CXCL13 and CXCL9 as diagnostic and therapy monitoring markers in central nervous system lymphoma

被引：0
|
作者：
Masouris, I. [1 ]
Pfirnnann, M. [2 ]
Manz, K. [2 ]
Koedeli, U. [1 ]
Von Baumgarten, L. [1 ]
机构：
[1] Ludwig Maximilians Univ Munchen, Dept ofNeurol, Munich, Germany
[2] Ludwig Maximilians Univ Munchen, Fac Med, Inst Med Informat Proc Biometry & Epidemiol, Munich, Germany
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2020年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
EPR2209
引用
收藏
页码：392 / 392
页数：1
相关论文
共 50 条
  • [21] CXCL13: a valuable biomarker for monitoring lupus flares?
    Fruhauf, I.
    Werner, S.
    Krainberger, I.
    Schwantzer, G.
    Sturm, Gl
    Aberer, E.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2008, 128 : S181 - S181
  • [22] Raised levels of CXCL12 and CXCL13 in cerebrospinal fluid of patients with CNS lymphoma
    Fischer, L.
    Kiewe, P.
    Pfeiffer, S.
    Korfel, A.
    Cakiroglu, H.
    Thiel, E.
    ANNALS OF ONCOLOGY, 2008, 19 : 224 - 224
  • [23] CXCL12 and CXCL13 levels in cerebrospinal fluid (CSF) of patients with CNS lymphoma
    Fischer, Lars
    Kiewe, Philipp
    Pfeiffer, Sebastian
    Cakiroglu, Husniye
    Thiel, Eckhard
    BLOOD, 2007, 110 (11) : 471A - 471A
  • [24] The lymphoid chemokine, CXCL13, is dispensable for the initial recruitment of B cells to the acutely inflamed central nervous system
    Rainey-Barger, Emily K.
    Rumble, Julie M.
    Lalor, Stephen J.
    Esen, Nilufer
    Segal, Benjamin M.
    Irani, David N.
    BRAIN BEHAVIOR AND IMMUNITY, 2011, 25 (05) : 922 - 931
  • [25] Identification of PSMB9 and CXCL13 as Immune-related Diagnostic Markers for Rheumatoid Arthritis by Machine Learning
    Li, Zhuo
    Chen, Yue
    Zulipikaer, Maimaiti
    Xu, Chi
    Fu, Jun
    Deng, Tao
    Hao, Li-Bo
    Chen, Ji-Ying
    CURRENT PHARMACEUTICAL DESIGN, 2022, 28 (34) : 2842 - 2854
  • [26] Expression of B-cell-attracting chemokine 1 (CXCL13) by malignant lymphocytes and vascular endothelium in primary central nervous system lymphoma
    Smith, JR
    Braziel, RM
    Paoletti, S
    Lipp, M
    Uguccioni, M
    Rosenbaum, JT
    BLOOD, 2003, 101 (03) : 815 - 821
  • [27] IP-10/CXCL10 and MIG/CXCL9 as novel markers for the diagnosis of lymphoma-associated hemophagocytic syndrome
    Hayato Maruoka
    Daichi Inoue
    Yoko Takiuchi
    Seiji Nagano
    Hiroshi Arima
    Sumie Tabata
    Akiko Matsushita
    Takayuki Ishikawa
    Tatsuo Oita
    Takayuki Takahashi
    Annals of Hematology, 2014, 93 : 393 - 401
  • [28] Plasma chemokines CXCL10 and CXCL9 as potential diagnostic markers of drug-sensitive and drug-resistant tuberculosis
    Sampath, Pavithra
    Rajamanickam, Anuradha
    Thiruvengadam, Kannan
    Natarajan, Alangudi Palaniappan
    Hissar, Syed
    Dhanapal, Madhavan
    Thangavelu, Bharathiraja
    Jayabal, Lavanya
    Ramesh, Paranchi Murugesan
    Ranganathan, Uma Devi
    Babu, Subash
    Bethunaickan, Ramalingam
    SCIENTIFIC REPORTS, 2023, 13 (01):
  • [29] IP-10/CXCL10 and MIG/CXCL9 as novel markers for the diagnosis of lymphoma-associated hemophagocytic syndrome
    Maruoka, Hayato
    Inoue, Daichi
    Takiuchi, Yoko
    Nagano, Seiji
    Arima, Hiroshi
    Tabata, Sumie
    Matsushita, Akiko
    Ishikawa, Takayuki
    Oita, Tatsuo
    Takahashi, Takayuki
    ANNALS OF HEMATOLOGY, 2014, 93 (03) : 393 - 401
  • [30] The chemokine CXCL13 (BLC): A putative diagnostic marker for neuroborreliosis
    Rupprecht, TA
    Pfister, HW
    Angele, B
    Kastenbauer, S
    Wilske, B
    Koedel, U
    NEUROLOGY, 2005, 65 (03) : 448 - 450
12345